E-tegra Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms
NCT ID: NCT02485496
Last Updated: 2022-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
38 participants
OBSERVATIONAL
2015-06-30
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Altura Abdominal Aortic Aneurysm (AAA) Endograft Safety and Feasibility Study
NCT01346943
A Study in Patients With Thoracoabdominal Aortic Aneurysm Treated With the E-nside TAAA Multibranch Stent Graft System
NCT04383145
Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System
NCT01348828
Safety and Performance of Altura Endograft in Abdominal Aortic Aneurysm (AAA) Endovascular Repair
NCT01991756
A Clinical Study to Evaluate the Safety and Performance of the Modular AAA Stent-Graft System
NCT01368679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endovascular abdominal repair
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient must have an infrarenal aortic aneurysm with diameter \>5cm or an infrarenal aortic aneurysm with 4 to 5cm that has increased in size by 0.5cm in the last 6 months
* Patient must be available for the appropriate follow-up times for the duration of the study
* Patient has signed the informed consent before intervention
Exclusion Criteria
* Patients with infectious aneurysm
* Patients with inflammatory aneurysm
* Patients with pseudoaneurysm
* Patients with ruptured or traumatic aneurysm
* Patients with suprarenal, juxtarenal, or pararenal aneurysm
* Patients with aortic dissection
* Patients with a reversed conical neck that is defined as a \>3mm distal increase over a 15mm length
* Patients who have a congenital degenerative Collagen disease or connective tissue disorder
* Patients with thrombocytopenia
* Patients with creatinine \>2.4 mg/dl immediately before the Intervention
* Patients with hyperthyreosis
* Patients with malignancy needing chemotherapy or Radiation
* Patients who are enrolled in another clinical study
* Patients with life expectancy of less than 24 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
JOTEC GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sven Seifert, Dr.
Role: PRINCIPAL_INVESTIGATOR
Klinikum Chemnitz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Nantes
Nantes, , France
CHU Pontchaillou
Rennes, , France
Klinikum Chemnitz
Chemnitz, , Germany
Universitätsklinikum Leipzig
Leipzig, , Germany
Szpital Uniwersytecki im. dr. Antoniego Jurasza
Bydgoszcz, , Poland
Samodzielny Publiczny Szpital Kliniczny Nr 1
Lublin, , Poland
Samodzielny Publiczny Centralny Szpital Kliniczny
Warsaw, , Poland
Hospital Joan XXIII
Tarragona, , Spain
Hospital Clinico Universitario Valladolid
Valladolid, , Spain
Inselspital - Universitätsspital
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SECURE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.